JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Fred H. Splittgerber
Ivar Friedrich
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Günther, A.
Right arrow Articles by Friedrich, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Günther, A.
Right arrow Articles by Friedrich, I.
Related Collections
Right arrow Lung - transplantation

J Thorac Cardiovasc Surg 2004;127:344-354
© 2004 The American Association for Thoracic Surgery


General thoracic surgery

Surfactant abnormalities after single lung transplantation in dogs: Impact of bronchoscopic surfactant administration

Andreas Günther, MDa,*, Markus Balser, MDa, Reinhold Schmidt, PhDa, Philipp Markart, MDa, Alexander Olk, MDb, Jochen Börgermann, MDc, Fred H. Splittgerber, MDb, Werner Seeger, MDa, Ivar Friedrich, MDc

a Department of Internal Medicine, Justus Liebig University, Giessen, Germany
b Department of Cardiothoracic Surgery, Martin Luther University, Halle, Germany
c Department Thoracic and Cardiovascular Surgery, University Essen, Essen, Germany

Received for publication August 12, 2002; accepted for publication September 11, 2003.

* Address for reprints: Dr Andreas Günther, Department of Internal Medicine, Justus-Liebig-University Giessen, Klinikstrasse 36, D-35392 Giessen, Germany
andreas.guenther{at}innere.med.uni-giessen.de

OBJECTIVE: Disturbances of the alveolar surfactant system have been implicated in the pathogenesis of reperfusion injury. The aim of this study was to evaluate the influence of exogenous surfactant administration on surfactant properties in a model of single lung transplantation.

METHODS: We performed heterologous, left lung transplantation (+4°C ischemia; 24 hours, Euro-Collins solution) in 6 foxhounds (untreated) and in 6 animals that received calf lung surfactant extract (Alveofact) prior to explantation (only donor lung; 50 mg/kg body weight) and immediately after onset of reperfusion (both lungs, 200 mg/kg body weight). Separate but synchronized ventilation of each lung was performed, in a volume-controlled, pressure-limited mode, with animals in prone position. Bronchoalveolar lavage fluids were collected in pretransplantation lungs (control), after 24 hours of ischemia prior to transplantation (0 hours) and 6 and 12 hours after reperfusion in both the grafts and the recipient native lungs.

RESULTS: Ischemic storage per se did not provoke any changes of the surfactant system; however, severe alterations occurred within 6 hours of reperfusion, resulting in a severe loss of surface activity, including a decrease in the percentage of the large surfactant aggregate fraction, reduction of the surfactant apoproteins SP-B and SP-C, the dipalmitoyl molecular species of phosphatidylcholine and phosphatidylglycerol within the large surfactant aggregate fraction. These abnormalities were restricted to the graft, with virtually normal surfactant function and composition being found in the recipient native lung. Surfactant administration fully normalized the biochemical and largely improved the biophysical surfactant properties, alongside maintenance of lung gas exchange properties.

CONCLUSIONS: Severe surfactant abnormalities occur exclusively in the graft when performing separate, synchronized ventilation of each lung to attenuate ventilator-induced lung injury. Bronchoscopic surfactant administration provides protection against these abnormalities and may be a therapeutic strategy in lung transplantation.





This article has been cited by other articles:


Home page
Eur Respir JHome page
J. Sadovski, T. Kuchenbuch, C. Ruppert, A. Fehrenbach, M. Hirschburger, W. Padberg, A. Gunther, J. M. Hohlfeld, H. Fehrenbach, and V. Grau
Keratinocyte growth factor prevents intra-alveolar oedema in experimental lung isografts
Eur. Respir. J., January 1, 2008; 31(1): 21 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. Friedrich, J. Borgermann, F. H. Splittgerber, M. Brinkmann, J. C. Reidemeister, R. E. Silber, W. Seeger, R. Schmidt, and A. Gunther
Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs
J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 335 - 343.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The American Association for Thoracic Surgery.